Exciting webinar slated for this month! We are looking forward to hosting Lisa Yen and Tom Bajoras to discuss their story and experience as NET caregiver and patient. Mark your calendars for this exciting webinar! Thursday, March 28th at 12pm EST! https://t.co/Qdbj5NboAv
Results of our clinical trial of pembrolizumab and lenvatinib in NETs were just published! The biggest thank you to all the patients who participated and make it possible to contribute to this field every day.
https://t.co/bc01pjWpEJ
#neuroendocrine#ClinicalTrials
A very clinically relevant paper from the unstoppable @altoubaht and the Moffitt team. A minority of lung NETs have a uniform expression of SSTRs and SSTR-neg or weak tumors are common. Therefore, SSTR-directed therapy is not the solution for all.
https://t.co/c36vwXpD3Z
Moffitt NET Program @ NANETS 2023
Early Career Panel @MHaiderMD
APP/AHP Panel TValone, KSommerer
Tumor Board Panel TValone, El-Haddad
@MHepatobiliary@MoffittNews
I am looking forward to the course and meeting the rising CGSO fellows!
Big thanks to @Medtronic and our other sponsors that make this course possible.
Excited to have @AGangiMD@SyedAAhmad5@megimenez joining us as guest faculty this year!